Allegedly, according to recent findings, these structures from J&J 'vaccine' microscopy by Dr. Zandré Botha are what appear to be microbubbles that can be used as a drug delivery system.

from Dr. Botha's microscopy findings

In 1967, infants and toddlers immunized with a formalin-inactivated vaccine against respiratory syncytial virus (RSV) experienced an enhanced form of RSV disease when they became infected with wild-type virus, resulting in the death of two vaccinated toddlers due to the nonprotective antibody response created by the vaccine. This antibody dependant enhancement of disease created immune complex deposits in the lungs triggering an aggressive inflammation response resulting in high fever, bronchopneumonia, and wheezing.

PHE data shows vaccinated are 39% of cases but 64% of deaths

The 20th technical report from Public Health England shows that from 1 February 2021 to 2 August 2021; despite being only 39% (117,115) of the confirmed delta infections, of the 742 deaths from the delta variant, 64% (481) are in the partly or fully vaccinated.

~4,500% more likely to die from the vaccine than from COVID

https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00069-0/fulltext

Moderna, Pfizer-BioNTech, AstraZeneca, Janssen COVID ‘vaccines’ are cited in a new patent, recently approved on August 31, 2021, for remote contact tracing of all ‘vaccinated’ individuals worldwide.

What is described appears to presume that the 'vaccinated' will be connected to the Internet of Bodies.

"SUMMARY OF THE INVENTION

Following is a non-exclusive list including some examples of embodiments of the invention. The invention also includes embodiments, which include fewer than all the features in an example, and embodiments using features from multiple examples, also if not expressly listed below.

Example 1. An anonymized method of treating subjects against an infectious disease caused by a pathogen, comprising:

a. providing an electronic device with proximity tracking circuitry for each of said subjects;

b. generating an ID for each said electronic device;

c. at a proximity event, when a particular said electronic device of a particular said subject is in proximity of one or more other of said electronic devices, one or both of transmitting said ID or an indication thereof to said one or more other devices and receiving an ID or indication thereof from said one or more other devices, by said particular electronic device;

d. generating, by said particular electronic device a score reflecting a propensity for proximity, according to a plurality of received IDs;

e. generating for said particular electronic device a prioritization of treatment based on said score;

f. treating said particular subject according to said prioritization.”

The Riddle of COVID-19